Invesco
TTPH

Invesco’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Invesco’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,564
Closed -$69K – 3819
2019
Q1 		$69K Sell
2,564
-125
-5% -$3.18K ﹤0.01% 3692
2018
Q4 		$61K Buy
2,689
+405
+18% +$15.8K ﹤0.01% 3683
2018
Q3 		$126K Buy
2,284
+20
+0.9% +$1.28K ﹤0.01% 3763
2018
Q2 		$162K Buy
+2,264
New +$160K ﹤0.01% 3736
2018
Q1 		– Sell
-2,569
Closed -$324K – 3802
2017
Q4 		$324K Sell
2,569
-13
-0.5% -$1.67K ﹤0.01% 3425
2017
Q3 		$353K Buy
2,582
+200
+8% +$26.8K ﹤0.01% 3406
2017
Q2 		$340K Sell
2,382
-2,002
-46% -$309K ﹤0.01% 3445
2017
Q1 		$806K Buy
4,384
+2,649
+153% +$297K ﹤0.01% 3146
2016
Q4 		$140K Buy
1,735
+182
+12% +$14.4K ﹤0.01% 3593
2016
Q3 		$119K Buy
1,553
+11
+0.7% +$881 ﹤0.01% 3583
2016
Q2 		$133K Buy
+1,542
New +$141K ﹤0.01% 3606
2015
Q3 		– Sell
-2,244
Closed -$2.13M – 4114
2015
Q2 		$2.13M Sell
2,244
-1
-0% -$818 ﹤0.01% 2568
2015
Q1 		$1.65M Buy
2,245
+504
+29% +$379K ﹤0.01% 2732
2014
Q4 		$1.38M Sell
1,741
-2,174
-56% -$1.17M ﹤0.01% 2753
2014
Q3 		$1.56M Buy
+3,915
New +$1.05M ﹤0.01% 2691
2014
Q1 		– Sell
-250
Closed -$68K – 4353
2013
Q4 		$68K Buy
250
+50
+25% +$11.9K ﹤0.01% 4071
2013
Q3 		$46K Buy
+200
New +$34.9K ﹤0.01% 4091

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Invesco's TTPH Position: Q2 2019 in Review

Invesco sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 2,564 shares — an estimated $69K sold.

Invesco first reported a position in TTPH in Q3 2013 and held it in 17 quarters. The position peaked at $2.13M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

  • Invesco reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Invesco sold 2,564 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $69K.
  • Invesco first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 17 quarters.
  • Invesco's Tetraphase Pharmaceuticals, Inc. position peaked at $2.13M in Q2 2015.
  • 66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on Invesco's 13F filing for Q2 2019, filed 14 Aug 2019.